In patients with invasive ductal carcinoma who were completely negative for hormone receptors, only the modified PVN classification showed significantly increasing trend hazard ratios for tumour recurrence and tumour-related death in the multivariate analyses (Table 6). This evidence concerns the gene NR4A1 and invasive ductal breast carcinoma.